Redefining Non-Small Cell Lung Cancer Care: Updates in Targeted and Perioperative Therapy

Redefining Non-Small Cell Lung Cancer Care: Updates in Targeted and Perioperative Therapy

From Deep Breaths: Updates from CHEST by ReachMD

December 22, 2025 · 17 min

About this episode

The episode discusses significant updates in non-small cell lung cancer care from recent conferences, focusing on targeted therapies and perioperative strategies.

Guest: Gerard A. Silvestri MD, MS, Master FCCP Guest: Mariam Alexander, MD, PhD Guest: Jessica S. Donington, MD, MSCR The 2025 European Society for Medical Oncology Congress and World Conference on Lung Cancer revealed significant updates in non-small cell lung cancer care. Learn more as Drs. Gerard Silvestri, Mariam Alexander, and Jessica Donington review new data on EGFR- and ROS1-targeted therapies, perioperative immunotherapy, and multidisciplinary strategies to expand resectability in stage III non-small cell lung cancer. Dr. Silvestri is a pulmonologist and the Hillenbrand Professor of Thoracic Oncology at the Medical University of South Carolina. Dr. Alexander is an Assistant Professor of Medical Oncology at the Medical University of South Carolina. Dr. Donington is a Professor in Surgery and Chief of the Section of Thoracic Surgery at the University of Chicago. This program is produced in partnership with the American College of Chest Physicians and is sponsored by AstraZeneca.

People in this episode

Hosts: Gerard A. Silvestri, Mariam Alexander, Gerard Silvestri

Guests: Gerard A Silvestri Md Ms Master Fccp, Mariam Alexander Md Phd, Jessica S Donington Md Mscr

Topics covered

  • non-small cell lung cancer
  • targeted therapy
  • perioperative therapy
  • immunotherapy
  • multidisciplinary strategies

Keywords

  • EGFR
  • ROS1
  • resectability
  • stage III lung cancer

Sponsors

AstraZeneca

More episodes of Deep Breaths: Updates from CHEST

Explore listener stats, chart rankings, contacts and more on the Deep Breaths: Updates from CHEST podcast page.